Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
about
The Potential Role of Kallistatin in the Development of Abdominal Aortic AneurysmKallikrein-kinin in stem cell therapyTissue kallikrein and bradykinin B2 receptors in the reproductive tract of the male ratAltered protein expression at early-stage rat hepatic neoplasia.Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stressPlasma kallistatin levels in patients with severe community-acquired pneumonia.Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signalingRole of human tissue kallikrein in gastrointestinal stromal tumour invasion.The kallikrein-kinin system in humans.Bradykinin antagonist counteracts the acute effect of both angiotensin-converting enzyme inhibition and of angiotensin receptor blockade on the lower limit of autoregulation of cerebral blood flow.Angiogenesis in diabetes and obesityAortic implantation of mesenchymal stem cells after aneurysm injury in a porcine modelIncreased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosisDelivery of recombinant adeno-associated virus-mediated human tissue kallikrein for therapy of chronic renal failure in ratsPlasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescentsInvolvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive ratsAntiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.Increased kallistatin levels in patients with obesity and prediabetes compared to normal glucose tolerance.Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression.Adeno-associated virus-mediated expression of kallistatin suppresses local and remote hepatocellular carcinomas.AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions.Increased serum kallistatin levels in type 1 diabetes patients with vascular complicationsProtective Role of Kallistatin in Vascular and Organ Injury.Endothelial AT(2)-receptors: chicken or egg?Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway.Kallistatin as a marker of microvascular complications in children and adolescents with type 1 diabetes mellitus: Relation to carotid intima media thickness.Cirrhosis of liver: Interference of serpins in quantification of SERPINA4 - A preliminary study.
P2860
Q26741231-76FEE303-EEA2-4F4E-B3D2-C52BE3AF291CQ27010386-6F07EDDB-B197-4398-9A1D-0FF97AD51804Q28575511-20739313-17A2-4541-B7FA-5FDE2033F2F7Q33271648-18F7B2EA-5744-40AA-94CF-37EE614514E8Q33727573-9C24CB5F-5E99-48A1-ABD2-B219860686ECQ33752812-3F0DE29A-B94F-43AE-9867-6D75980855BBQ33787188-8407DE5B-227D-4ECC-85C2-34E4800120FBQ34344121-6E20CF7F-FA78-4B75-BAC0-8B5E259F7F05Q34570447-651622D0-0CA0-4832-8A2F-8F3AAC4FC68BQ35064653-E509F4E2-A0AE-4715-9B2B-9A7D38A8F240Q35153884-BCE2FEC0-C663-4B46-BED3-A9F7E4C0B0F1Q35159130-12785E6C-0BB4-4B32-BA17-0B5B9FC56F3CQ35555319-7F153E32-38F1-4962-9DAD-E3C64F40DE8FQ36029511-1F8C5D53-93EE-4058-8D7C-AAA9BCF4A176Q36237963-C120345D-A3D7-4EE2-A7D0-80D2C46D17BCQ36646387-384E9207-FB67-4295-ADEA-F3A9ED2C017DQ37133031-0C986014-B434-47B3-9ECD-7657C45491CEQ37233325-106AE580-4397-4092-851D-8AF993BD7BD0Q37333523-3969EDE8-7591-401E-B79F-ACF0106F6D59Q38838756-DDAD807E-E05B-4269-946D-D647B0E08E26Q39458426-864E0F7C-1333-444A-9495-77EB656B4219Q40002803-7F9E5AF2-2A8D-457D-963B-56921322C2ECQ42014112-2F1C8F64-50AC-45AC-BC3C-85623496A835Q42034969-F6D0900C-847C-4253-A11A-4D813EF22A89Q42360588-A7251862-CEA4-48A4-BB22-7EEF6B543B26Q43263750-F28F1EA0-4864-4B9F-B5B7-E4DD2010A5FBQ47554530-0D7A50A2-4A88-4B94-ABCB-D5EB7A750A48Q48129770-AD345199-1874-44DB-987B-206E40500134Q51301114-BED25E99-CEA6-4A8C-814F-F6B8A18F815BQ55008681-E8A58F62-CE5D-4265-8BCB-E6021609E3FA
P2860
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@ast
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@en
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@nl
type
label
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@ast
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@en
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@nl
prefLabel
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@ast
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@en
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@nl
P2093
P2860
P1476
Localization and expression of tissue kallikrein and kallistatin in human blood vessels.
@en
P2093
P2860
P304
P356
10.1177/002215549904700210
P577
1999-02-01T00:00:00Z